Morgan Stanley Asia Singapore sells 17.32 lakh shares of Aurobindo Pharma: Report

31 May 2014 Evaluate

Morgan Stanley Asia Singapore has sold 17.32 lakh shares of Aurobindo Pharma through the open market route. The shares were sold on an average price of Rs 669.92 valuing the transaction at Rs 116.06 crore. On the other hand, Abu Dhabi Investment Authority has bought 14.75 shares in the company for an average price of Rs 670.51, through open market route valuing the transaction at Rs 98.95 crore.

Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s robust product portfolio is spread over 6 major therapeutic/product areas encompassing Antibiotics, Anti-Retrovirals, CVS, CNS, Gastroenterologicals, and Anti-Allergics, supported by an outstanding R&D set-up.

Aurobindo Pharma Share Price

1187.20 -11.80 (-0.98%)
30-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.60
Dr. Reddys Lab 1265.95
Cipla 1491.40
Zydus Lifesciences 901.30
Lupin 2081.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×